RS

Rajendrakumar Satyanarayan Holani

Active Director Additional Director DIN 01182657
DIN 01182657 First appointment Aug 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Aug 2004
Shareholding value •••• Premium profile

About Rajendrakumar Satyanarayan Holani

Data last updated:

Rajendrakumar Satyanarayan Holani is an Additional Director at Chemserves Pharma Private Limited (since 2016), Director at Fruition Trading Private Limited (since 2018) and Additional Director at Relichem Pharma Private Limited (since 2017). The companies operate in Pharma, Metals and Minerals and Consumer Goods. The 3 current companies with reported revenue have a combined latest revenue of ₹93.1 Lakh; the largest is Chemserves Pharma Private Limited at ₹59.7 Lakh (FY 2019). Earlier, Rajendrakumar Satyanarayan Holani was a Director at Care Integrated Services Private Limited (2004–2015).

DIN 01182657
Primary Designation Additional Director
Industry Pharma
First Appointment 18 Aug 2004
Oldest Company Age 17 yrs
Largest company Chemserves Pharma Private Limited · ₹59.7 Lakh (FY 2019)
Combined revenue ₹93.1 Lakh across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemserves Pharma Private Limited U24100MH2009PTC191943
Additional Director10 Oct 20162009₹59.7 Lakh (FY 2019)Active
Fruition Trading Private Limited U51909MH2018PTC309589
Director18 May 20182018₹33.2 Lakh (FY 2024)Active
Relichem Pharma Private Limited U74120MH2012PTC235716
Additional Director10 Jan 20172012₹13,846 (FY 2019)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Aug 20042000₹6.92 Cr (FY 2016)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemserves Pharma Private Limited
Fruition Trading Private Limited
Relichem Pharma Private Limited
Care Integrated Services Private Limited
Premium access

Shareholding and investment profile for Rajendrakumar Satyanarayan Holani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendrakumar Satyanarayan Holani

Rajendrakumar Satyanarayan Holani currently holds 3 directorships: Chemserves Pharma Private Limited (Additional Director, since 10 Oct 2016, revenue ₹59.7 Lakh (FY 2019)); Fruition Trading Private Limited (Director, since 18 May 2018, revenue ₹33.2 Lakh (FY 2024)); Relichem Pharma Private Limited (Additional Director, since 10 Jan 2017, revenue ₹13,846 (FY 2019)).

Rajendrakumar Satyanarayan Holani was first appointed on 18 Aug 2004 as Director at Care Integrated Services Private Limited. The most recent appointment on record is 18 May 2018 at Fruition Trading Private Limited.

The 3 current companies of Rajendrakumar Satyanarayan Holani that report revenue have a combined latest revenue of ₹93.1 Lakh: Chemserves Pharma Private Limited ₹59.7 Lakh (FY 2019); Fruition Trading Private Limited ₹33.2 Lakh (FY 2024); Relichem Pharma Private Limited ₹13,846 (FY 2019).

Rajendrakumar Satyanarayan Holani held 1 earlier board appointment: Care Integrated Services Private Limited (Director, 18 Aug 2004 to 14 Jan 2015).

The current boards of Rajendrakumar Satyanarayan Holani's companies include Rohitash Kailashchand Mandhana (Chemserves Pharma Private Limited), Suresh Mandhana (Chemserves Pharma Private Limited), Pawankumar Holani (Fruition Trading Private Limited), Vinod Kumar Holani (Fruition Trading Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available